CAPTRUST FINANCIAL ADVISORS - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 198 filers reported holding NOVOCURE LTD in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2022$86,000
+17.8%
1,239
+41.0%
0.00%
Q1 2022$73,000
+28.1%
879
+16.7%
0.00%
Q4 2021$57,000
-36.0%
753
-1.3%
0.00%
-100.0%
Q3 2021$89,000
-66.7%
763
-36.7%
0.00%
-50.0%
Q2 2021$267,000
+468.1%
1,205
+240.4%
0.00%
+100.0%
Q1 2021$47,000
+213.3%
354
+316.5%
0.00%
Q4 2020$15,000
+50.0%
850.0%0.00%
Q3 2020$10,000
-28.6%
85
-62.7%
0.00%
Q2 2020$14,000
-64.1%
228
-55.8%
0.00%
-100.0%
Q3 2019$39,000
+69.6%
516
+41.0%
0.00%0.0%
Q2 2019$23,0003660.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2019
NameSharesValueWeighting ↓
StepStone Group LP 1,365,479$29,767,00021.90%
Tamarack Advisers, LP 1,115,000$24,307,00011.56%
COURAGE CAPITAL MANAGEMENT LLC 275,000$5,995,0004.57%
GREAT POINT PARTNERS LLC 753,481$16,426,000,0002.44%
HARTLINE INVESTMENT CORP/ 404,052$8,808,0002.42%
Pier Capital, LLC 346,350$7,550,0001.29%
Rhenman & Partners Asset Management AB 435,000$9,483,0001.17%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,029,910$22,452,0000.77%
PEREGRINE CAPITAL MANAGEMENT LLC 922,468$20,110,0000.49%
Hodges Capital Management Inc. 285,500$6,224,0000.49%
View complete list of NOVOCURE LTD shareholders